DS
KYNB

DRW Securities’s Kyntra Bio KYNB Stock Holding History

DRW Securities’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,420
Closed -$267K – 1450
2025
Q4 		$267K Buy
30,420
+19,205
+171% +$188K 0.01% 746
2025
Q3 		$137K Buy
+11,215
New +$105K ﹤0.01% 1146
2016
Q2 		– Sell
-600
Closed -$319K – 79
2016
Q1 		$319K Buy
+600
New +$299K 0.02% 61
2015
Q4 		– Sell
-600
Closed -$329K – 85
2015
Q3 		$329K Buy
+600
New +$363K 0.04% 55

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

DRW Securities's KYNB Position: Q1 2026 in Review

DRW Securities sold out of Kyntra Bio (KYNB) in Q1 2026, closing a stake of 30,420 shares — an estimated $267K sold.

DRW Securities first reported a position in KYNB in Q3 2015 and held it in 4 quarters. The position peaked at $329K in Q3 2015. 32 funds tracked by Wall St. Rank hold KYNB as of Q1 2026.

  • DRW Securities reported no remaining Kyntra Bio position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 30,420 Kyntra Bio shares in Q1 2026, an estimated $267K.
  • DRW Securities first reported a position in Kyntra Bio in Q3 2015 and held it in 4 quarters.
  • DRW Securities's Kyntra Bio position peaked at $329K in Q3 2015.
  • 32 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.